Aspergillus-related chronic lung disease
This clinical statement sets out best practice in the diagnosis and management of chronic fungal lung disease.
The Clinical Statement is available to download below and can also be seen in the Thorax journal.
Watch a BTS webinar introducing the clinical statement
Filter by:
| Title | Publication Date | Description | Status | |
|---|---|---|---|---|
| 00 BTS Clinical Statement on Aspergillus-related chronic pulmonary disease | 20250501May 2025 | Covers diagnosis, management and use of antifungal therapy. | Valid | READ MORE |
| 01 Supplementary tables 1 & 2 - BTS Clinical Statement on Aspergillus-related chronic pulmonary disease | 20250501May 2025 | Pharmacology, common side effects and interactions for triazole antifungal agents and intravenous antifungal agents. | Valid | READ MORE |
